B cell activating factor (BAFF): structure, functions, autoimmunity and clinical implications in systemic lupus erythematosus (SLE)

T Möckel, F Basta, J Weinmann-Menke… - Autoimmunity reviews, 2021 - Elsevier
The B cell activating factor (BAFF), or B lymphocyte stimulator (BLyS), is a B cell survival
factor which supports autoreactive B cells and prevents their deletion. BAFF expression is …

B cell abnormalities in systemic lupus erythematosus and lupus nephritis—role in pathogenesis and effect of immunosuppressive treatments

DYH Yap, TM Chan - International journal of molecular sciences, 2019 - mdpi.com
Abnormalities in B cells play pivotal roles in the pathogenesis of systemic lupus
erythematosus (SLE) and lupus nephritis (LN). Breach in central and peripheral tolerance …

Efficacy and Safety of Atacicept in Patients With Systemic Lupus Erythematosus: Results of a Twenty‐Four–Week, Multicenter, Randomized, Double‐Blind, Placebo …

JT Merrill, DJ Wallace, S Wax, A Kao… - Arthritis & …, 2018 - Wiley Online Library
Objective To evaluate the efficacy and safety of atacicept, an antagonist of B lymphocyte
stimulator/APRIL–mediated B cell activation, in patients with systemic lupus erythematosus …

Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases

E Samy, S Wax, B Huard, H Hess… - International reviews of …, 2017 - Taylor & Francis
The B cell-stimulating molecules, BAFF (B cell activating factor) and APRIL (a proliferation-
inducing ligand), are critical factors in the maintenance of the B cell pool and humoral …

Pathways leading to an immunological disease: systemic lupus erythematosus

O Zharkova, T Celhar, PD Cravens… - …, 2017 - academic.oup.com
SLE is a chronic autoimmune disease caused by perturbations of the immune system. The
clinical presentation is heterogeneous, largely because of the multiple genetic and …

Telitacicept as a BLyS/APRIL dual inhibitor for autoimmune disease

F Shi, R Xue, X Zhou, P Shen, S Wang… - Immunopharmacology …, 2021 - Taylor & Francis
The pathogenic roles for B cells in autoimmunity include produce pathogenic autoantibodies
and modulate immune responses via the production of cytokines and chemokines. The B …

Plasma cell differentiation pathways in systemic lupus erythematosus

S Malkiel, AN Barlev, Y Atisha-Fregoso… - Frontiers in …, 2018 - frontiersin.org
Plasma cells (PCs) are responsible for the production of protective antibodies against
infectious agents but they also produce pathogenic antibodies in autoimmune diseases …

B cell metabolism and autophagy in autoimmunity

IGA Raza, AJ Clarke - Frontiers in Immunology, 2021 - frontiersin.org
B cells are central to the pathogenesis of multiple autoimmune diseases, through antigen
presentation, cytokine secretion, and the production of autoantibodies. During development …

Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approaches

A Merino‐Vico, G Frazzei… - European journal of …, 2023 - Wiley Online Library
Autoimmune diseases are characterized by the recognition of self‐antigens by the immune
system, which leads to inflammation and tissue damage. B cells are directly and indirectly …

B cell checkpoints in autoimmune rheumatic diseases

SJS Rubin, MS Bloom, WH Robinson - Nature Reviews Rheumatology, 2019 - nature.com
B cells have important functions in the pathogenesis of autoimmune diseases, including
autoimmune rheumatic diseases. In addition to producing autoantibodies, B cells contribute …